Aim: Extended-spectrum beta-lactamases and AmpC beta-lactamases give resistance to Enterobacteriaceae against cephalosporins, which are important drugs in various clinical settings. Within 5 days, a total of eight strains of Citrobacter freundii and two strains of Escherichia coli, all of which were resistant to third-generation cephalosporins, were isolated from six different patients in a critical care center. We carried out epidemiological and genetic studies to confirm the situation to be an outbreak by a single strain or a betalactamase-producing gene.
Enterobacteriaceae are mostly sensitive to third-generation cephalosporins (3 rd cephem). However, in the presence of broad-spectrum beta-lactamases such as AmpC betalactamases (AmpC-BLs) and extended-spectrum betalactamases (ESBLs), the organisms can acquire broad resistance to these clinically important drugs.
Third-generation cephalosporin-resistant Citrobacter freundii was isolated from three different patients during three straight days in an 8-bed intensive care unit (ICU) and a 10-bed high care unit (HCU) of a medical facility in Japan. The ICU and HCU are on the same floor and separated only by a door. Initially, a 3 rd cephem-resistant C. freundii was isolated from burn wounds of a patient who had been admitted to the ICU for 18 days (patient I). The isolate was confirmed to be an ESBL-producing organism by disk diffusion antimicrobial test. The next day, the 3 rd cephem-resistant C. freundii was again isolated from sputum of another patient in the HCU (patient II). Furthermore, C. freundii with a same antibiotic susceptible pattern was detected from the peritoneal drainage tube of a second patient in the HCU (patient III). Active surveillance was carried out immediately for all of the ICU and HCU patients (sputum, urine, and stool) and a total of 40 points of high touch surfaces in the critical care facility, including tables, handrails of patients' beds, visiting cars, and sinks. As a result, we found that patient II carried the organism in stool, and patient III carried the organism in sputum and stool. The organism was also isolated from a third HCU patient (patient IV). All these isolates were found to be resistant to 3 rd cephem. In addition, two strains of 3 rd cephem-resistant E. coli were detected from the other two HCU patients. The environmental screening did not detect any multiple drug-resistant organisms (MDROs). Reinforcement of hygiene practices for staff and isolation of the carrier patients were implemented immediately and rigorously. Consequently, these highly drugresistant Enterobacteriaceae were not isolated from the other patients.
Later, we carried out a pulsed-field gel electrophoresis (PFGE) epidemiological study against the eight strains of C. freundii and two strains of E. coli (Fig. 1 ). In addition, polymerase chain reaction (PCR) analysis for the detection of ESBL genes (TEM, SHV, CTX-M-1, CTX-M-2, and CTX-M-9) 1 and multiplex PCR for plasmid-mediated AmpC-BL genes 2 were carried out. The PFGE analysis showed that lanes 2, 7, and 8, all derived from patient II, exhibited the same pattern (group A), and lanes 5 and 6, derived from patient III, exhibited the same pattern (group B). The other three C. freundii strains (lanes 1, 3, and 4) showed independent PFGE patterns. The PFGE group B strain possessed TEM and CTX-M-9. The two E. coli strains isolated during the active surveillance exhibited different PFGE patterns, carrying CTX-M-2 and CTX-M-9, respectively. The ESBL-negative C. freundii strains were all positive for CIT type AmpC-BL. The profiles of these isolates are shown in Table 1 .
At first, we considered the case as an outbreak induced by a single strain of highly drug-resistant C. freundii. However, based on the results of the PFGE analysis, the situation was considered not as an outbreak but as a concurrence of genetically different strains of MDROs. Although patients III and V were both positive for a relatively rare strain, C. freundii carrying the CTX-M-9 gene, the origins of the pathogens were assumed to be different as there was no epidemiological links between the two patients and the results of the PFGE patterns were totally different. Yet, the resistance gene could be reciprocally transferred during the hospital stay through plasmids. The genes of ESBLs are usually located on plasmids, and therefore, they are easily transmitted to other organisms, even beyond genus.
To date, many outbreaks of ESBL-producing Enterobacteriaceae have been reported. 3, 4 It has been reported that that transmission rate of ESBL-producing organisms in the ICU is low and specific isolation of the ESBL-positive patient is not required. 5 However, ICU patients are mostly vulnerable to infections and the emergence of MDROs has potentially a great impact on clinical practices. Additionally, from the aspect of the proper usage of antibiotics and for economic reasons, the wide spread of MDROs should be prevented as much as possible. Nada et al. once reported a small outbreak of 3 rd cephem-resistant C. freundii occurring in a surgical freundii (lanes 1, 3, and 4) and two strains of E. coli presented a different PFGE band pattern.
ward and emphasized the importance of taking heed of the nosocomial spread of the resistant strains. 6 We agree with their notion and contact precaution should be strengthened in such cases, especially when it is in the ICU.
Although it was not an outbreak, the present situation might indicate a more serious situation. That is, the concurrent existence of MDROs can be a dangerous hothouse for an outbreak. Constitutive monitoring of drug-resistant organisms, or "malignant" genes for resistance, is essential to prevent propagation and possible outbreaks. Appropriate contact precaution is classical but fundamental and is the most effective strategy, which must be strictly practiced in every clinical setting. 
